drugset / Trial / NCT02051764
Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
NaSingle-groupOpen-labelDiagnostic
Summary
This study will evaluate the imaging characteristics of flortaucipir in subjects with a previous flortaucipir scan in order to assess the rate of change of tau deposition over time.
Timeline
- Start
- 2014-05
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flortaucipir F18 | Diagnostic / imaging agent | 370 mbq | Intravenous |
| Background | florbetapir F 18 | Diagnostic / imaging agent | 370 mbq | Intravenous |